1-3 of 3
Rinpei Niwa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities

Akito Natsume, Mika In, Hiroyuki Takamura, Tomoaki Nakagawa, Yukiko Shimizu, Kazuko Kitajima, Masako Wakitani, So Ohta, Mitsuo Satoh, Kenya Shitara, Rinpei Niwa
Journal: Cancer Research
Cancer Res (2008) 68 (10): 3863–3872.
https://doi.org/10.1158/0008-5472.CAN-07-6297
Published: 15 May 2008
View articletitled, Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities
Open the PDF for Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities in another window
Journal Articles

Defucosylated chimeric anti-CCR4 IGG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma.

Kenya Shitara, Rinpei Niwa, Kazuyasu Nakamura, Shiro Akinaga, Nobuo Hanai, Kouji Matsushima, Ryuzo Ueda
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 572.
Published: 01 April 2004
View articletitled, Defucosylated chimeric anti-CCR4 IGG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma.
Journal Articles

Defucosylated Chimeric Anti-CC Chemokine Receptor 4 IgG1 with Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma

Rinpei Niwa, Emi Shoji-Hosaka, Mikiko Sakurada, Toyohide Shinkawa, Kazuhisa Uchida, Kazuyasu Nakamura, Kouji Matsushima, Ryuzo Ueda, Nobuo Hanai, Kenya Shitara
Journal: Cancer Research
Cancer Res (2004) 64 (6): 2127–2133.
https://doi.org/10.1158/0008-5472.CAN-03-2068
Published: 16 March 2004
View articletitled, Defucosylated Chimeric Anti-CC Chemokine Receptor 4 IgG1 with Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma
Open the PDF for Defucosylated Chimeric Anti-CC Chemokine Receptor 4 IgG1 with Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma in another window